Target intelligence / Profile preview

Nicotinamide riboside kinase 2 (NMRK2)

Target
NMRK2
Molecular classification
Enzyme
01

Overview

Nicotinamide riboside kinase 2 (NMRK2) is an enzyme responsible for catalyzing the phosphorylation of nicotinamide riboside (NR) and nicotinic acid riboside (NaR) to form nicotinamide mononucleotide (NMN) and nicotinic acid mononucleotide (NaMN), key intermediates in the NAD+ biosynthesis salvage pathway. NMRK2 is implicated in muscle physiology, including regulation of myogenesis, and may affect laminin matrix deposition and cell adhesion. Mutations or altered activity in NMRK2 may contribute to congenital muscular dystrophies and metabolic disorders involving NAD+ deficiency.

Other names
ITGB1BP3NRK2NRK 2NmR-K 2MIBPRNK 2Integrin beta-1-binding protein 3Muscle integrin-binding proteinNicotinic acid riboside kinase 2Ribosylnicotinamide kinase 2Ribosylnicotinic acid kinase 2muscle-specific beta 1 integrin binding protein
02

Biological functions

NAD+ biosynthetic process via the salvage pathwayPhosphorylation of nicotinamide riboside and nicotinic acid ribosideRegulation of terminal myogenesisNegative regulation of myoblast differentiationRegulation of PXN protein level and phosphorylation
03

Disease associations

Muscular dystrophy (specifically congenital muscular dystrophy due to integrin alpha-7 deficiency)Pellagra

Beyond the preview

Go deeper on Nicotinamide riboside kinase 2 (NMRK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinamide riboside kinase 2 (NMRK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call